ArticlePlastic and reconstructive surgery. Global open2026
Three-dimensional Bovine Collagen-Elastin Matrix in Soft Tissue Reconstruction: No Detectable Bovine DNA After 1 Year.
Article in Plastic and reconstructive surgery. Global open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Postoperative wound healing remains a critical challenge, particularly in complex reconstructions such as free flap surgeries. Despite technical improvements, perfusion-related complications may cause partial flap loss. Following wound stabilization, secondary measures such as vacuum-assisted closure therapy and skin grafting are required. Three-dimensional bovine collagen-elastin matrices offer promising support by enhancing cell migration, angiogenesis, and tissue regeneration. Methods: We report the case of a 43-year-old woman who developed partial necrosis after deep inferior epigastric perforator flap reconstruction. She was treated with vacuum-assisted closure therapy, followed by the application of MatriDerm 1 mm and split-thickness skin grafting. After 12 months, histological analysis and quantitative reverse transcription polymerase chain reaction (PCR) were performed on the grafted area to assess tissue integration and detect residual bovine DNA. Results: Histology showed full regeneration of the epidermis and dermis without detectable bovine matrix remnants. No elastic fibers from MatriDerm were visible, and quantitative reverse transcription PCR confirmed the absence of bovine DNA, despite ongoing tissue remodeling and macrophage infiltration. Conclusions: These findings demonstrate complete resorption and integration of a 3-dimensional bovine collagen-elastin matrix within 1 year, without immunologically relevant residues. Compared with other dermal substitutes such as Integra, MatriDerm shows faster degradation and a lower risk of foreign body reactions. The observed tissue remodeling indicates a prolonged regenerative process depending on wound type and depth. MatriDerm is a safe and effective dermal matrix, ensuring complete resorption and tissue integration. The absence of bovine DNA supports its immunologic safety and clinical suitability for complex wound treatment requiring durable and aesthetic outcomes.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.